Management of Febrile Thrombocytopenia in Children

Diagnostic Evaluation

The American College of Rheumatology recommends a complete blood count with manual differential to assess severity of cytopenias and identify abnormal cell morphology in children with febrile thrombocytopenia 1, 2
A peripheral blood smear is necessary to exclude pseudothrombocytopenia, identify schistocytes, and evaluate for malaria parasites in children with febrile thrombocytopenia 3, 2
The American College of Rheumatology suggests measuring C-reactive protein and erythrocyte sedimentation rate to assess for severe infections in children with febrile thrombocytopenia 1
A complete metabolic panel is recommended to assess for hyponatremia, hypoalbuminemia, and organ dysfunction in children with febrile thrombocytopenia 1

The European Hematology Association recommends initiating empiric broad-spectrum antimicrobial therapy immediately for profound neutropenia in children with febrile thrombocytopenia 4
The European Hematology Association suggests that fluoroquinolones decrease gram-negative infection incidence in prolonged granulocytopenia in children with febrile thrombocytopenia 4
Platelet transfusion is recommended if the platelet count is ≤10 × 10⁹/L regardless of bleeding, or if the platelet count is 10-20 × 10⁹/L with fever and/or infection in children with febrile thrombocytopenia 4

The American College of Rheumatology recommends diagnostic criteria for MIS-C, including fever, epidemiologic link to SARS-CoV-2, elevated ESR/CRP with lymphopenia, neutrophilia, thrombocytopenia, hyponatremia, or hypoalbuminemia, and multi-system involvement 1
The American College of Cardiology recommends cardiac monitoring, including EKG every 48 hours, echocardiogram at diagnosis, 7-14 days, and 4-6 weeks, and trending BNP and troponin T until normalized in children with MIS-C 1
The American Society of Hematology recommends treatment for primary ITP only if clinically significant bleeding is present, or if mucous membrane bleeding is present with platelets <20,000/mm³ in children with primary ITP 3, 5, 7, 8

The American Academy of Pediatrics recommends not assuming ITP in a child with fever, abdominal pain, joint pain, and pancytopenia, as this constellation suggests infection or bone marrow pathology, not primary ITP 2
The American Academy of Pediatrics suggests not delaying bone marrow examination when pancytopenia is present, as missing leukemia or bone marrow failure has catastrophic mortality implications 2
The American Academy of Pediatrics recommends not withholding empiric antibiotics while awaiting cultures, as mortality in febrile thrombocytopenia correlates with multiorgan dysfunction from untreated infection, not platelet count 4
The American Academy of Pediatrics suggests not administering NSAIDs or aspirin, as these impair platelet function and increase bleeding risk even with moderate thrombocytopenia 5
The American Academy of Pediatrics recommends not treating based solely on platelet number, as bleeding severity should dictate treatment decisions 3, 5, 6